Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Trading Statement

21 Jan 2026 07:00

RNS Number : 6610P
Galliford Try Holdings PLC
21 January 2026
 

Galliford Try Holdings plc

Trading Update

Wednesday 21 January 2026

 

 

Continued progression in H1 and increased confidence in full year delivery

 

Galliford Try Holdings plc, a leading FTSE 250 construction group, today provides an update on trading for the half year from 1 July 2025 to 31 December 2025. The Group expects to announce its results for the half year on Wednesday 4 March 2026.

 

Update on Current Trading

 

The Group's businesses are performing well, with trading ahead of the prior year, and the Board's expectations. Our strong market position in our chosen sectors and extensive participation in national long-term frameworks - particularly in transportation, education, defence, custodial and health - is well aligned with the Government's future spending plans. The significantly enlarged AMP8 water framework programmes are progressing in line with expectations.

Given the outlook, we now expect revenue for the full financial year to be towards the upper end of current market expectations and for adjusted profit before tax to be slightly above the top end of current market expectations.1

1 The range of analysts' forecasts for the year ending 30 June 2026, based on forecasts at 19 January 2026, is for revenue of £1,900m to £1,922m and adjusted profit before tax of £46.8m to £47.7m.

 

Balance Sheet

 

The average month-end cash for the rolling 12 months ended 31 December 2025 was £189.9m (year to 30 June 2025: £178.7m) and period-end cash at 31 December 2025 was £211.7m (31 December 2024: £210.0m). The Group continues to maintain a portfolio of PPP assets and has no debt or pensions liabilities.  The Group's revolving credit facility, established last year, remains undrawn.

 

We believe the Group's strong balance sheet differentiates our ability to secure high quality contracts and frameworks, to attract a highly skilled supply chain and continue to invest in the business whilst providing incremental returns to shareholders.

 

Share Buyback

 

On 17 September 2025, the Group launched its third share buyback programme of up to a maximum of £10.0m. As at 19 January 2026 the Group had purchased a total of 1,579,151 shares, for an aggregate consideration of £8.0m.

 

Order Book and Outlook

 

Our order book of £4.1bn (31 December 2024: £3.9bn) is predominantly in long-term frameworks providing high visibility of future workload. We continue to see a strong pipeline of medium and long-term opportunities across our chosen sectors, supported by our track record and focus on the public and regulated sectors alongside high-quality private clients.

 

Since the start of the financial year the Group's notable framework wins include:

 

- a place on National Grid's £9.0bn Major Works & Civils Framework, Lot 1 - Converter Civils & Buildings, as part of the HVDC programme,

- a place on the £3.0bn affordable homes framework across the East, South and London regions for the Registered Provider, The Hyde Group, and

- reappointment to the £1.0bn YORCivil Major Works 2 Framework.

 

 

Bill Hocking, Chief Executive, commented:

 

"We are pleased with our recent framework and project wins as well as the opportunities we continue to see across all our chosen sectors. The Group benefits from having a strong balance sheet and a high-quality carefully selected order book, and our ongoing investment in our excellent people continues to build strong project teams to consistently deliver for our clients. 

 

The Group's businesses have performed well in the first half, supporting further confidence in delivering strong results in the current financial year. We remain focussed on driving long-term value creation for all our stakeholders as we deliver our Sustainable Growth Strategy to 2030."

 

 

For further enquiries please contact:

 

Galliford Try

Bill Hocking, Chief Executive

Kris Hampson, Chief Financial Officer

Kevin Corbett, General Counsel & Company Secretary

01895 855001

Teneo 

James Macey White/Ffion Dash

 

020 7260 2700

 

The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary.

 

Note to Editors

Galliford Try is a trading name of Galliford Try Holdings plc, a leading FTSE 250 UK construction group. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure (environment and highways) projects with clients in the public, private and regulated sectors across the UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDBUSDDGLG
Date   Source Headline
23rd Oct 202410:00 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 202411:30 amRNSAnnual Financial Report
16th Oct 20241:00 pmRNSDirector/PDMR Shareholding
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 202410:30 amRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20243:50 pmRNSDirector/PDMR Shareholding
8th Oct 20243:45 pmRNSDirector/PDMR Shareholding
8th Oct 20243:45 pmRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20245:25 pmRNSDirector/PDMR Shareholding
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:02 amRNSLaunch of Share Buyback Programme
3rd Oct 20247:00 amRNSFinal Results
30th Sep 20243:00 pmRNSTotal Voting Rights
24th Sep 20247:00 amRNSContract
23rd Sep 20247:00 amRNSContract
20th Sep 20248:44 amRNSNotification of Full Year Results
16th Sep 20247:01 amRNS2024 Full Year Results: Revised Publication Date
2nd Sep 20242:30 pmRNSDirector Declaration
2nd Sep 202410:30 amRNSTotal Voting Rights
27th Aug 20244:14 pmRNSBlock listing Interim Review
16th Aug 20249:30 amRNSContract
31st Jul 20244:00 pmRNSTotal Voting Rights
24th Jul 202410:30 amRNSDirector Declaration
23rd Jul 20247:00 amRNSContract
11th Jul 20247:00 amRNSTrading Statement
28th Jun 202411:00 amRNSTotal Voting Rights
13th Jun 20247:00 amRNSContract
31st May 20244:00 pmRNSTotal Voting Rights
31st May 20247:00 amRNSContract
23rd May 20247:00 amRNSCapital Markets Event
30th Apr 20244:00 pmRNSTotal Voting Rights
23rd Apr 20244:00 pmRNSDirector/PDMR Shareholding
10th Apr 20245:00 pmRNSHolding(s) in Company
5th Apr 202411:00 amRNSTotal Voting Rights
28th Mar 20247:00 amRNSDirectorate Change
8th Mar 20244:00 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSHalf-year Report
4th Mar 20244:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
26th Feb 20246:03 pmRNSBlock listing Interim Review
22nd Feb 20247:00 amRNSContract
17th Jan 20247:00 amRNSTrading Statement
30th Nov 20234:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.